Noroclav 500 mg Palatable Tablets for Dogs
Noroclav 500 mg Palatable Tablets for Dogs
Authorised
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Noroclav 500 mg Palatable Tablets for Dogs
Noroclav 500 mg comprimidos palatáveis para cães
Active substance:
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Potassium clavulanate119.13/milligram(s)1.00Tablet
-
Amoxicillin trihydrate459.22/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Available in:
-
Portugal
Package description:
- Aluminium/aluminium blister strips, each containing 5 tablets. Cartons of 10 tablets.
- Aluminium/aluminium blister strips, each containing 5 tablets. Cartons of 20 tablets.
- Aluminium/aluminium blister strips, each containing 5 tablets. Cartons of 25 tablets.
- Aluminium/aluminium blister strips, each containing 5 tablets. Cartons of 100 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Manufacturing Limited
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 027/01/07RFVPT
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0547/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
France
-
Luxembourg
-
Netherlands
-
Norway
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
